Halma plc -.4% potential downside indicated by Barclays

Broker Ratings

Halma plc with ticker (LON:HLMA) now has a potential downside of -.4% according to Barclays.



Barclays set a target price of 2,100 GBX for the company, which when compared to the Halma plc share price of 2,109 GBX at opening today (11/10/2022) indicates a potential downside of -.4%. Trading has ranged between 1,855 (52 week low) and 3,270 (52 week high) with an average of 1,070,391 shares exchanging hands daily. The market capitalisation at the time of writing is £7,987,737,112.

Halma plc is a United Kingdom-based life-saving technology company. The Company operates through three segments. The Safety segment provides technologies that save lives, protect infrastructure and enable safe movement, and also technologies that protect people and assets at work across a range of critical industrial and logistics operations. The segment provides solutions for elevator safety, fire suppression, people and vehicle flow, fire detection, pressure management, safe storage and transfer, and industrial access control. The Environmental & Analysis segment provides technologies, which monitor and protect the environment and ensure the quality and availability of life-critical resources. The segment’s solutions include environmental monitoring, gas detection, optical analysis, and water analysis and treatment. The Medical segment provides medical technologies, which enhance the quality of patients’ lives and improve the quality of care delivered by healthcare providers.



Share on:
Find more news, interviews, share price & company profile here for:

    Halma Plc CFO Steve Gunning to retire, Carole Cran appointed as CFO Designate

    Halma plc announces CFO transition with Steve Gunning retiring in 2025 and Carole Cran stepping in, continuing the company's growth strategy.

    Halma plc achieves record H1 results, continued dividend growth

    Halma plc (LON:HLMA) reports strong half-year results, announcing a 7% interim dividend increase, boosting shareholder returns in 2024.

    Halma Plc acquires Lamidey Noury, enhancing minimally invasive surgical solutions

    Halma Plc acquires Lamidey Noury Medical, expanding its healthcare portfolio with advanced electrosurgical devices for minimally invasive procedures.

      Search

      Search